Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) shares are trading lower by 19.9% to 72 cents Wednesday afternoon after the company announced a 1-for-8 reverse stock split. What Else: Sonnet ...
Sonnet BioTherapeutics’s SONN shares rose 16.17% on receiving investigational new drug (IND) application clearance from the FDA to initiate a clinical study of its lead candidate, SON-1010, in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results